ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,859.85
0.00%
US Tech 100
19,900.00
0.00%
Dow Jones
43,065.22
0.00%
Brent Oil
74.10
-1.08%
Bitcoin
65,811.61
-0.37%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Day One Biopharmaceuticals Inc (DAWN) Quote

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc (DAWN)

NASDAQ
14.30
0.42
(3.03%)
Closed October 14 4:00PM
Delayed by 15 minutes
14.30
0.00
( 0.00% )
Pre Market: 8:29AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
14.30
Bid
13.97
Ask
14.67
Volume
102
0.00 Day's Range 0.00
9.67 52 Week Range 18.0699
Market Cap
1.406B
Previous Close
14.30
Open
-
Last Trade
27
@
14.3
Last Trade Time
08:00:02
Financial Volume
-
VWAP
-
Average Volume (3m)
1,002,915
Shares Outstanding
98,310,000
Dividend Yield
-
PE Ratio
-7.44
Earnings Per Share (EPS)
-1.92
Revenue
-
Net Profit
-188.92M

About Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with c... Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.dayonebio.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Day One Biopharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DAWN. The last closing price for Day One Biopharmaceuticals was $14.30. Over the last year, Day One Biopharmaceuticals shares have traded in a share price range of $ 9.67 to $ 18.0699.

Day One Biopharmaceuticals currently has 98,310,000 shares outstanding. The market capitalization of Day One Biopharmaceuticals is $1.41 billion. Day One Biopharmaceuticals has a price to earnings ratio (PE ratio) of -7.44.

Ask ADVFN Intelligence (AI)

DAWN Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

September 12 2024
Edgar (US Regulatory)

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

August 28 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

August 19 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

August 19 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

August 16 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

August 16 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

August 05 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 02 2024
Edgar (US Regulatory)

Form 8-K - Current report

July 30 2024
Edgar (US Regulatory)

Form 8-K - Current report

July 30 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.6754.9541284403713.62514.5513.42109179413.88162297CS
40.5053.6607466473413.79514.9113.41103663114.02357367CS
12-0.55-3.703703703714.8516.7512.64100291514.13360997CS
260.453.2490974729213.8518.069911.94108838114.52562086CS
523.1928.712871287111.1118.06999.6787923614.18786478CS
156-8.51-37.308198158722.8128.34995.4478658315.16810148CS
260-10.7-42.82528.6995.4471138815.34118306CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZPTAZapata Computing Holdings Inc
$ 0.1548
(101.04%)
73.36M
DBGIDigital Brands Group Inc
$ 0.3003
(87.92%)
23.61M
BDSXBiodesix Inc
$ 2.37
(48.13%)
173
BNZIBanzai International Inc
$ 5.47
(47.84%)
5.98M
GRTSGritstone bio Inc
$ 0.073
(35.19%)
103.51M
QRTEBQurate Retail Inc
$ 2.14
(-44.13%)
159
NTBLNotable Labs Ltd
$ 0.2676
(-33.10%)
434.01k
FUNDSprott Focus Trust Inc
$ 6.01
(-22.25%)
64
STIMNeuronetics Inc
$ 0.713
(-19.89%)
2
SRPTSarepta Therapeutics Inc New
$ 100.0012
(-19.59%)
2
GRTSGritstone bio Inc
$ 0.073
(35.19%)
103.51M
ZPTAZapata Computing Holdings Inc
$ 0.1539
(99.87%)
73.4M
DBGIDigital Brands Group Inc
$ 0.30
(87.73%)
23.62M
LIPOLipella Pharmaceuticals Inc
$ 0.4713
(15.32%)
17.6M
ENVBEnveric Biosciences Inc
$ 0.4283
(3.96%)
12.5M

Discussion

View Full Feed
crazy horse 0 crazy horse 0 2 minutes ago
NC Hurricane where was our Military

https://www.tiktok.com/t/ZTFHLP6fY/
ccore10 ccore10 2 minutes ago
NSAV has self valued their crypto, and its not backed by liquid funds, so who would they sell their coins to? If they could have they would have but they cant because their tokens arent worth anything outside of their ZEUS ecosystem.

They could have 50 billion in crypto yet there is
NSAV
TrendTrade2016 TrendTrade2016 2 minutes ago
AND OUT
ZPTA
Awl416 Awl416 3 minutes ago
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
IMRX
Hopeforthefuture3 Hopeforthefuture3 3 minutes ago
Bio, just give up and admit you are incorrect and quit digging your hole deeper. Later today for those interested in facts I will post more details of the official SAP as completed by the consultant for nwbo. Nwbo or jama or NYAS discloses the trial results for several of the secondary endpoints- so
NWBO
jimmybob jimmybob 3 minutes ago
Morning Watch List : https://www.optionmillionaires.com/october-15th-2024-watch-list/
RKMKE RKMKE 3 minutes ago
Again BS???

So tell us why are you bullish or pumping WDLF? Is there anything retail don’t know or you are admitting you know something that only insider knows?
WDLF
jimmybob jimmybob 3 minutes ago
GM FOLKSSS
jimmybob jimmybob 3 minutes ago
lol
SuperLogisticsMan SuperLogisticsMan 3 minutes ago
UAS-Pro... Recently saw on X that Brett Velicovich @DronerWarrior joined the advisory board of $RCAT. What do you think of that? I wonder if Brett is noi longer advising $CYBL. Conflict of interest?
CYBL RCAT
Jack_Herer Jack_Herer 3 minutes ago
What are they constructing? A Zen garden for the hippies?

Noting that D&B Mining's tiny (0.05 sq km) mining lease expired more than 2 years ago and they do not appear to be in any hurry to renew it.
Quoting recent correspondence from Mineral Resources Tasmania staff, "The Minin
HIRU
x993231 x993231 3 minutes ago
Hardly boring, I've been here from the day they decided to create a polymer (plastic) from scratch that could control light by switching it on and off very fast, clean it, stabilize it, prove its compatibility with silicon and the processes in the Silicon Foundries so that it could be mass-produced.
NVDA
maddyandboomer maddyandboomer 4 minutes ago
2. The CD issue are sins of the past but, by law, the company must issue shares to mature notes when conversions are sent in to T/A....
AXXA
RKMKE RKMKE 4 minutes ago
Again BS???

So tell us why are you bullish or pumping WDLF? Is there anything retail don’t know or you are admitting you know something that only insiders know?
WDLF
threewheeler threewheeler 4 minutes ago
4.5B share offering wtf https://www.otcmarkets.com/filing/html?id=17821296&guid=MEL-kKpyTAvnJth
CBDL
CaptainObvious CaptainObvious 5 minutes ago
Oh my. Lol
NWBO
TrendTrade2016 TrendTrade2016 5 minutes ago
BACK IN
ZPTA
Invest-in-America Invest-in-America 5 minutes ago
ZPTA: Go-figure!!! It's an obviously Upside-Down universe we reside in, Homeboys!!! (Firm crashes-&-burns horribly, but their stock SOARS !!!)

" GEORGE ORR " runs the " Lather of Heaven Wall Street "!!!!!!!!
ZPTA
Konaploinks Konaploinks 5 minutes ago
4 years ago ….

. December 9, 2020
by Peter Chapman, President and CEO
https://images.ctfassets.net/hqm865gc1xfs/4IMJnA61DhS7bD4vVeWFf9/6455f7fca0764c74703eac4a37b289ff/IonQ-roadmap-20201208.jpeg

Today, how many people buy a computer based on the number of
IONQ
maddyandboomer maddyandboomer 6 minutes ago
1. They raised A/S again to 2.5 billion
AXXA
Jackxkr Jackxkr 6 minutes ago
How many shares do you
own?
NWBO
MartinLutherKing MartinLutherKing 6 minutes ago
ZPTA Space shuttle liftoff
ZPTA
FROZENFLAME FROZENFLAME 6 minutes ago
Watch this garbage probably close red by the end of the day !
SIDU
investingnotgambling investingnotgambling 7 minutes ago
Thank you for your continued diligence and I am truly sorry that you are needing to waste your time responding to pepeoil. I am sure there are better ways to spend your time.
GPLS
Rainer Rainer 7 minutes ago
https://www.otcmarkets.com/stock/RONN/news/Ronn-Announces-NYC-Visit-to-Sign-Joint-Venture-Agreement-with-Hydrogen-Energy-Systems?id=455719
RONN

Your Recent History

NASDAQ
DAWN
Day One Biopharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved